{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:56:34Z","timestamp":1791244594906,"version":"4.1.0"},"reference-count":174,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"DOI":"10.1007\/s00280-026-04949-y","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:18:33Z","timestamp":1789629513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Modulating PI3K\/Akt\/mTOR-driven autophagy in liver cancer. The role of phytochemicals"],"prefix":"10.1007","volume":"96","author":[{"given":"Poonam","family":"Lal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"4949_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2022.08.021","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J et al (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol Published Online First: 7 Oct. https:\/\/doi.org\/10.1016\/j.jhep.2022.08.021","journal-title":"J Hepatol Published Online First: 7 Oct"},{"key":"4949_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41575-024-01021-z","volume":"22","author":"YH Yeo","year":"2025","unstructured":"Yeo YH, Abdelmalek M, Khan S, Moylan CA, Rodriquez L, Villanueva A, Yang JD (2025) Current and emerging strategies for the prevention of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 22:173\u2013190. https:\/\/doi.org\/10.1038\/s41575-024-01021-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4949_CR3","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","volume":"34","author":"DQ Huang","year":"2022","unstructured":"Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R (2022) Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metabol 34:969\u2013977e2. https:\/\/doi.org\/10.1016\/j.cmet.2022.05.003","journal-title":"Cell Metabol"},{"key":"4949_CR4","doi-asserted-by":"publisher","unstructured":"Motta BM, Masarone M, Torre P, Persico M From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention. Cancers. Published Online First: 19 November 2023. https:\/\/doi.org\/10.3390\/cancers15225458","DOI":"10.3390\/cancers15225458"},{"key":"4949_CR5","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4609360","author":"PHC Diniz","year":"2020","unstructured":"Diniz PHC, Silva SDC, Vidigal PVT, Xavier MAP, Lima CX, Faria LC, Ferrari TCA (2020) Expression of MAPK and PI3K\/AKT\/mTOR Proteins according to the Chronic Liver Disease Etiology in Hepatocellular Carcinoma. J Oncol Published Online First: 29 Oct. https:\/\/doi.org\/10.1155\/2020\/4609360","journal-title":"J Oncol Published Online First: 29 Oct"},{"key":"4949_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9111639","author":"EJ Sun","year":"2021","unstructured":"Sun EJ, Wankell M, Palamuthusingam P, McFarlane C, Hebbard L (2021) Targeting the PI3K\/Akt\/mTOR Pathway in Hepatocellular Carcinoma. Biomedicines Published Online First: 8 November. https:\/\/doi.org\/10.3390\/biomedicines9111639","journal-title":"Biomedicines Published Online First: 8 November"},{"key":"4949_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106553","author":"MDA Paskeh","year":"2023","unstructured":"Paskeh MDA, Ghadyani F, Hashemi M et al (2023) Biological impact and therapeutic perspective of targeting PI3K\/Akt signalling in hepatocellular carcinoma: Promises and Challenges. Pharmacol Res Published Online First: 1 January. https:\/\/doi.org\/10.1016\/j.phrs.2022.106553","journal-title":"Pharmacol Res Published Online First: 1 January"},{"key":"4949_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06537-9","author":"Z Quan","year":"2025","unstructured":"Quan Z, Peng B, Hu K et al (2025) AP5Z1 affects hepatocellular carcinoma growth and autophagy by regulating PTEN ubiquitination and modulating the PI3K\/Akt\/mTOR pathway. J Translational Med Published Online First: 20 May. https:\/\/doi.org\/10.1186\/s12967-025-06537-9","journal-title":"J Translational Med Published Online First: 20 May"},{"key":"4949_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1186\/s12864-021-07876-9","volume":"22","author":"C Dimitrakopoulos","year":"2021","unstructured":"Dimitrakopoulos C, Hindupur SK, Colombi M et al (2021) Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma. BMC Genomics 22:592. https:\/\/doi.org\/10.1186\/s12864-021-07876-9","journal-title":"BMC Genomics"},{"key":"4949_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216744","author":"G Wang","year":"2024","unstructured":"Wang G, Jiang X, Torabian P, Yang Z (2024) Investigating autophagy and intricate cellular mechanisms in hepatocellular carcinoma: Emphasis on cell death mechanism crosstalk. Cancer Lett Published Online First: 1 April. https:\/\/doi.org\/10.1016\/j.canlet.2024.216744","journal-title":"Cancer Lett Published Online First: 1 April"},{"key":"4949_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/27694127.2024.2326241","author":"H Shalhoub","year":"2024","unstructured":"Shalhoub H, Gonzalez P, Santos AD, Guillermet-Guibert J, Moniaux N, Dupont N, Faivre J (2024) Simultaneous activation and blockade of autophagy to fight hepatocellular carcinoma. Autophagy Rep Published Online First: 30 March. https:\/\/doi.org\/10.1080\/27694127.2024.2326241","journal-title":"Autophagy Rep Published Online First: 30 March"},{"key":"4949_CR12","doi-asserted-by":"publisher","first-page":"106789","DOI":"10.1016\/j.phrs.2023.106789","volume":"192","author":"L Gu","year":"2023","unstructured":"Gu L, Jin X, Liang H, Yang C, Zhang Y (2023) Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15\/EGFR complex. Pharmacol Res 192:106789. https:\/\/doi.org\/10.1016\/j.phrs.2023.106789","journal-title":"Pharmacol Res"},{"key":"4949_CR13","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B2200038","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li Q, Ren S et al (2022) Investigation and experimental validation of curcumin-related mechanisms against hepatocellular carcinoma based on network pharmacology. J Zhejiang University: Sci B Published Online First: 21 August. https:\/\/doi.org\/10.1631\/jzus.B2200038","journal-title":"J Zhejiang University: Sci B Published Online First: 21 August"},{"key":"4949_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12935-025-03988-4","volume":"25","author":"M Esmaeli","year":"2025","unstructured":"Esmaeli M, Dehabadi MD, Ghanbari A (2025) Molecular targets and therapeutic implications of curcumin in hepatocellular carcinoma: a comprehensive literature review. Cancer Cell Int 25:335. https:\/\/doi.org\/10.1186\/s12935-025-03988-4","journal-title":"Cancer Cell Int"},{"key":"4949_CR15","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1002\/ptr.7082","volume":"35","author":"S Patra","year":"2021","unstructured":"Patra S, Pradhan B, Nayak R et al (2021) Apoptosis and autophagy modulating dietary phytochemicals in cancer therapeutics: Current evidences and future perspectives. Phytother Res 35:4194\u20134214. https:\/\/doi.org\/10.1002\/ptr.7082","journal-title":"Phytother Res"},{"key":"4949_CR16","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.s270124","author":"L Song","year":"2020","unstructured":"Song L, Luo Y, Li S, Hong M, Wang Q, Chi X, Yang C (2020) ISL Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via Downregulation of PI3K\/AKT\/mTOR Pathway in vivo and in vitro. Drug Design, Development and Therapy. Published Online First: 1 Oct. https:\/\/doi.org\/10.2147\/dddt.s270124","journal-title":"Published Online First: 1 Oct"},{"key":"4949_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prmcm.2023.100233","author":"S Bhattacharya","year":"2023","unstructured":"Bhattacharya S, Perris A, Jawed JJ, Hoda M (2023) Therapeutic role of resveratrol against hepatocellular carcinoma: A review on its molecular mechanisms of action. Pharmacol Res - Mod Chin Med Published Online First: 1 March. https:\/\/doi.org\/10.1016\/j.prmcm.2023.100233","journal-title":"Pharmacol Res - Mod Chin Med Published Online First: 1 March"},{"key":"4949_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY et al (2023) PI3K\/AKT\/mTOR signalling transduction pathway and targeted therapies in cancer. Mol Cancer Published Online First: 19 August. https:\/\/doi.org\/10.1186\/s12943-023-01827-6","journal-title":"Mol Cancer Published Online First: 19 August"},{"key":"4949_CR19","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12885-022-09357-y","volume":"22","author":"K Narci","year":"2022","unstructured":"Narci K, Kahraman DC, Koyas A, Ersahin T, Tuncbag N, Atalay RC (2022) Context dependent isoform specific PI3K inhibition confers drug resistance in hepatocellular carcinoma cells. BMC Cancer 22:320. https:\/\/doi.org\/10.1186\/s12885-022-09357-y","journal-title":"BMC Cancer"},{"key":"4949_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2024.1378386","author":"J Chen","year":"2024","unstructured":"Chen J, He F, Peng H, Guo J (2024) The underlying mechanism and targeted therapy strategy of miRNAs cross-regulating EMT process through multiple signalling pathways in hepatocellular carcinoma. Front Mol Biosci Published Online First: 22 March. https:\/\/doi.org\/10.3389\/fmolb.2024.1378386","journal-title":"Front Mol Biosci Published Online First: 22 March"},{"key":"4949_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01608-z","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M et al (2023) Multifaceted role of mTOR (mammalian target of rapamycin) signalling pathway in human health and disease. Signal Transduction and Targeted Therapy. Published Online First: 2 Oct. https:\/\/doi.org\/10.1038\/s41392-023-01608-z","journal-title":"Published Online First: 2 Oct"},{"key":"4949_CR22","doi-asserted-by":"publisher","unstructured":"Wang Y, Engel T, Teng X (2024) Post-translational regulation of the mTORC1 pathway: A switch that regulates metabolism-related gene expression. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1867:195005. https:\/\/doi.org\/10.1016\/j.bbagrm.2024.195005","DOI":"10.1016\/j.bbagrm.2024.195005"},{"key":"4949_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B (2021) Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Therapy Published Online First: 1 Dec. https:\/\/doi.org\/10.1038\/s41392-021-00828-5","journal-title":"Signal Transduct Target Therapy Published Online First: 1 Dec"},{"key":"4949_CR24","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1016\/S1470-2045(23)00676-9","volume":"25","author":"IM Browne","year":"2024","unstructured":"Browne IM, Andr\u00e9 F, Chandarlapaty S, Carey LA, Turner NC (2024) Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer. Lancet Oncol 25:e139\u2013e151. https:\/\/doi.org\/10.1016\/S1470-2045(23)00676-9","journal-title":"Lancet Oncol"},{"key":"4949_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.105778","author":"SLL Park","year":"2024","unstructured":"Park SLL, Ram\u00edrez-Jarqu\u00edn UN, Shahani N et al (2024) SUMO Modifies G\u03b2L and Mediates mTOR Signalling. J Biol Chem Published Online First: 1 Febr. https:\/\/doi.org\/10.1016\/j.jbc.2024.105778","journal-title":"J Biol Chem Published Online First: 1 Febr"},{"key":"4949_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14225520","author":"A Bouyahya","year":"2022","unstructured":"Bouyahya A, Allam AE, Aboulaghras S et al (2022) Targeting mTOR as a Cancer Therapy: Recent Advances in Natural Bioactive Compounds and Immunotherapy. Cancers Published Online First: 11 November. https:\/\/doi.org\/10.3390\/cancers14225520","journal-title":"Cancers Published Online First: 11 November"},{"key":"4949_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06462-2","author":"MJ Ramaiah","year":"2021","unstructured":"Ramaiah MJ, Kumar KR (2021) mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme. Mol Biology Rep Published Online First: 1 May. https:\/\/doi.org\/10.1007\/s11033-021-06462-2","journal-title":"Mol Biology Rep Published Online First: 1 May"},{"key":"4949_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112160","author":"R Hablase","year":"2024","unstructured":"Hablase R, Kyrou I, Randeva H, Karteris E, Chatterjee J (2024) The \u2018Road\u2019 to Malignant Transformation from Endometriosis to Endometriosis-Associated Ovarian Cancers (EAOCs): An mTOR-Centred Review. Cancers Published Online First: 7 June. https:\/\/doi.org\/10.3390\/cancers16112160","journal-title":"Cancers Published Online First: 7 June"},{"key":"4949_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45110546","author":"J Chen","year":"2023","unstructured":"Chen J, Rodriguez AS, Morales MA, Fang X (2023) Autophagy Modulation and Its Implications on Glioblastoma Treatment. Current Issues in Molecular Biology. Published Online First: 29 Oct. https:\/\/doi.org\/10.3390\/cimb45110546","journal-title":"Published Online First: 29 Oct"},{"key":"4949_CR30","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-gmb-2020-0014","author":"LB Reis","year":"2021","unstructured":"Reis LB, Filippi-Chiela EC, Ashton-Prolla P, Visioli F, Rosset C (2021) The paradox of autophagy in Tuberous Sclerosis Complex. Genetics and Molecular Biology. Published Online First: 1 January. https:\/\/doi.org\/10.1590\/1678-4685-gmb-2020-0014","journal-title":"Published Online First: 1 January"},{"key":"4949_CR31","doi-asserted-by":"publisher","unstructured":"Roudsari NM, Lashgari N-A, Momtaz S et al (2021) Inhibitors of the PI3K\/Akt\/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention. Pharmaceutics. Published Online First: 3 August https:\/\/doi.org\/10.3390\/pharmaceutics13081195","DOI":"10.3390\/pharmaceutics13081195"},{"key":"4949_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2017.12.010","author":"S Nagini","year":"2019","unstructured":"Nagini S, Sophia J, Mishra R (2019) Glycogen synthase kinases: Moonlighting proteins with theranostic potential in cancer. Seminars Cancer Biology Published Online First: 1 June. https:\/\/doi.org\/10.1016\/j.semcancer.2017.12.010","journal-title":"Seminars Cancer Biology Published Online First: 1 June"},{"key":"4949_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0216-7","author":"G Hoxhaj","year":"2019","unstructured":"Hoxhaj G, Manning BD (2019) The PI3K\u2013AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Reviews Cancer Published Online First: 4 November. https:\/\/doi.org\/10.1038\/s41568-019-0216-7","journal-title":"Nat Reviews Cancer Published Online First: 4 November"},{"key":"4949_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110350","author":"SD Precilla","year":"2022","unstructured":"Precilla SD, Biswas I, Kuduvalli SS, Anitha TS (2022) Crosstalk between PI3K\/AKT\/mTOR and WNT\/\u03b2-Catenin signalling in GBM - Could combination therapy checkmate the collusion? Cellular Signalling. Published Online First: 1 July. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110350","journal-title":"Published Online First: 1 July"},{"key":"4949_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-1022-4","author":"M Song","year":"2020","unstructured":"Song M, Pan Q, Yang J et al (2020) Galectin-3 favours tumour metastasis via the activation of \u03b2-catenin signalling in hepatocellular carcinoma. Br J Cancer Published Online First: 17 August. https:\/\/doi.org\/10.1038\/s41416-020-1022-4","journal-title":"Br J Cancer Published Online First: 17 August"},{"key":"4949_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-023-10136-9","author":"A Bishayee","year":"2023","unstructured":"Bishayee A (2023) Modulation of hypoxia-inducible factor-1 signalling pathways in cancer angiogenesis, invasion, and metastasis by natural compounds: a comprehensive and critical review. Cancer Metastasis Reviews Published Online First: 5 Oct. https:\/\/doi.org\/10.1007\/s10555-023-10136-9","journal-title":"Cancer Metastasis Reviews Published Online First: 5 Oct"},{"key":"4949_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054746","author":"D Boi","year":"2023","unstructured":"Boi D, Rubini E, Breccia S, Guarguaglini G, Paiardini A (2023) When Just One Phosphate Is One Too Many: The Multifaceted Interplay between Myc and Kinases. Int J Mol Sci Published Online First: 2 March. https:\/\/doi.org\/10.3390\/ijms24054746","journal-title":"Int J Mol Sci Published Online First: 2 March"},{"key":"4949_CR38","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1158\/0008-5472.CAN-25-1615","volume":"85","author":"G Cui","year":"2025","unstructured":"Cui G, Zhou Y, Liao W et al (2025) Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma. Cancer Res 85:5049\u20135065. https:\/\/doi.org\/10.1158\/0008-5472.CAN-25-1615","journal-title":"Cancer Res"},{"key":"4949_CR39","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.7150\/thno.38711","volume":"10","author":"S Zhang","year":"2020","unstructured":"Zhang S, Gao W, Tang J et al (2020) The Roles of GSK-3\u03b2 in Regulation of Retinoid Signalling and Sorafenib Treatment Response in Hepatocellular Carcinoma. Theranostics 10:1230\u20131244. https:\/\/doi.org\/10.7150\/thno.38711","journal-title":"Theranostics"},{"key":"4949_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.08.003","author":"G Fang","year":"2019","unstructured":"Fang G, Zhang P, Liu J, Zhang X, Zhu X, Li R, Wang H (2019) Inhibition of GSK-3\u03b2 activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK\/mTOR signalling. Cancer Lett Published Online First: 1 Oct. https:\/\/doi.org\/10.1016\/j.canlet.2019.08.003","journal-title":"Cancer Lett Published Online First: 1 Oct"},{"key":"4949_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-023-04511-z","author":"J Liu","year":"2023","unstructured":"Liu J (2023) Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K\/AKT\/GSK-3\u03b2 Pathway. Applied Biochemistry and Biotechnology. Published Online First: 3 May. https:\/\/doi.org\/10.1007\/s12010-023-04511-z","journal-title":"Published Online First: 3 May"},{"key":"4949_CR42","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1007\/s13577-024-01081-y","volume":"37","author":"R Wang","year":"2024","unstructured":"Wang R, Tang D, Ou L, Jiang J, Wu Y, Tian X (2024) \u03b2-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression. Hum Cell 37:1156\u20131169. https:\/\/doi.org\/10.1007\/s13577-024-01081-y","journal-title":"Hum Cell"},{"key":"4949_CR43","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1007\/s12010-023-04511-z","volume":"195","author":"H Shao","year":"2023","unstructured":"Shao H, Chen J, Li A et al (2023) Salvigenin Suppresses Hepatocellular Carcinoma Glycolysis and Chemoresistance Through Inactivating the PI3K\/AKT\/GSK-3\u03b2 Pathway. Appl Biochem Biotechnol 195:5217\u20135237. https:\/\/doi.org\/10.1007\/s12010-023-04511-z","journal-title":"Appl Biochem Biotechnol"},{"key":"4949_CR44","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.120.265637","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Wu H, Xing X et al (2020) CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38\/Hsp27\/CREB\/ATG7 Pathway. J Pharmacol Experimental Ther Published Online First: 22 June. https:\/\/doi.org\/10.1124\/jpet.120.265637","journal-title":"J Pharmacol Experimental Ther Published Online First: 22 June"},{"key":"4949_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7354700","author":"S Lin","year":"2022","unstructured":"Lin S, Sheng Q, Ma X et al (2022) Marsdenia tenacissima Extract Induces Autophagy and Apoptosis of Hepatocellular Cells via MIF\/mToR Signalling. Evidence-based Complementary and Alternative Medicine. Published Online First: 4 March. https:\/\/doi.org\/10.1155\/2022\/7354700","journal-title":"Published Online First: 4 March"},{"key":"4949_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121894","author":"S Siapoush","year":"2023","unstructured":"Siapoush S, Rezaei R, Alavifard H et al (2023) Therapeutic implications of targeting autophagy and TGF-\u03b2 crosstalk for the treatment of liver fibrosis. Life Sci Published Online First: 27 June. https:\/\/doi.org\/10.1016\/j.lfs.2023.121894","journal-title":"Life Sci Published Online First: 27 June"},{"key":"4949_CR47","doi-asserted-by":"publisher","unstructured":"Benhammou JN, Sinnett-Smith J, Pisegna JR, Rozengurt EJ: Interplay Between Fatty Acids, Desaturase S-C-A (2023) Mechanistic Target of Rapamycin, and Yes-Associated Protein\/Transcriptional Coactivator With PDZ-Binding Motif in Promoting Hepatocellular Carcinoma. Gastro Hep Advances. Published Online First: 1 January https:\/\/doi.org\/10.1016\/j.gastha.2022.07.017","DOI":"10.1016\/j.gastha.2022.07.017"},{"key":"4949_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.595242","author":"R Sun","year":"2020","unstructured":"Sun R, Xu Y, Zhang H, Yang Q, Wang K, Shi Y, Wang Z (2020) Mechanistic Modeling of Gene Regulation and Metabolism Identifies Potential Targets for Hepatocellular Carcinoma. Frontiers in Genetics. Published Online First: 23 Dec. https:\/\/doi.org\/10.3389\/fgene.2020.595242","journal-title":"Published Online First: 23 Dec"},{"key":"4949_CR49","doi-asserted-by":"publisher","first-page":"155932582110110","DOI":"10.1177\/15593258211011023","volume":"19","author":"J Lin","year":"2021","unstructured":"Lin J, Ruan J, Zhu H, Chen Z, Chen J, Yu H (2021) Tenacissoside H Induces Autophagy and Radiosensitivity of Hepatocellular Carcinoma Cells by PI3K\/Akt\/mTOR Signalling Pathway. Dose-Response 19:15593258211011023. https:\/\/doi.org\/10.1177\/15593258211011023","journal-title":"Dose-Response"},{"key":"4949_CR50","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096389157250917055438","author":"A Naqi","year":"2025","unstructured":"Naqi A, Khan MA, Khatoon Z et al (2025) Regulation of the PI3K\/AKT\/mTOR cascade in Hepatocellular Carcinoma Using Flavonoid Molecules. Current cancer drug targets. Published Online First: 2 Oct. https:\/\/doi.org\/10.2174\/0115680096389157250917055438","journal-title":"Published Online First: 2 Oct"},{"key":"4949_CR51","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/ptr.8103","volume":"38","author":"Y Chen","year":"2024","unstructured":"Chen Y, Tan X, Zhang W et al (2024) Natural products targeting macroautophagy signalling in hepatocellular carcinoma therapy: Recent evidence and perspectives. Phytother Res 38:1623\u20131650. https:\/\/doi.org\/10.1002\/ptr.8103","journal-title":"Phytother Res"},{"key":"4949_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.70126","author":"G Xiufeng","year":"2025","unstructured":"Xiufeng G, Zhiping H, Jingzhi W (2025) Advantages and Possibility of Transcription Factors FOXOs in HCC. Cell Biochemistry and Function. Published Online First: 26 September. https:\/\/doi.org\/10.1002\/cbf.70126","journal-title":"Published Online First: 26 September"},{"key":"4949_CR53","doi-asserted-by":"publisher","first-page":"667730","DOI":"10.3389\/fonc.2021.667730","volume":"11","author":"S Yang","year":"2021","unstructured":"Yang S, Pang L, Dai W et al (2021) Role of Forkhead Box O Proteins in Hepatocellular Carcinoma Biology and Progression (Review). Front Oncol 11:667730. https:\/\/doi.org\/10.3389\/fonc.2021.667730","journal-title":"Front Oncol"},{"key":"4949_CR54","doi-asserted-by":"publisher","first-page":"1213506","DOI":"10.3389\/fphar.2023.1213506","volume":"14","author":"S Tu","year":"2023","unstructured":"Tu S, Qiu Y (2023) Molecular subtypes and scoring tools related to Foxo signalling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness. Front Pharmacol 14:1213506. https:\/\/doi.org\/10.3389\/fphar.2023.1213506","journal-title":"Front Pharmacol"},{"key":"4949_CR55","doi-asserted-by":"publisher","DOI":"10.1515\/almed-2023-0014","author":"E Fern\u00e1ndez-Gal\u00e1n","year":"2023","unstructured":"Fern\u00e1ndez-Gal\u00e1n E, Sandalinas S, Macias-Mu\u00f1oz L et al (2023) Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients. Advances in Laboratory Medicine \/ Avances en Medicina de Laboratorio. Published Online First: 12 July. https:\/\/doi.org\/10.1515\/almed-2023-0014","journal-title":"Published Online First: 12 July"},{"key":"4949_CR56","doi-asserted-by":"publisher","unstructured":"Fondevila F, Fern\u00e1ndez-Palanca P, M\u00e9ndez-Blanco C et al (2021) Association of FOXO3 Expression with Tumour Pathogenesis, Prognosis and Clinicopathological Features in Hepatocellular Carcinoma: A Systematic Review with Meta-Analysis. Cancers. Published Online First: 26 October https:\/\/doi.org\/10.3390\/cancers13215349","DOI":"10.3390\/cancers13215349"},{"key":"4949_CR57","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1038\/s41598-020-63895-8","volume":"10","author":"F Lallemand","year":"2020","unstructured":"Lallemand F, Vacher S, De Koning L et al (2020) The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis. Sci Rep 10:6920. https:\/\/doi.org\/10.1038\/s41598-020-63895-8","journal-title":"Sci Rep"},{"key":"4949_CR58","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1002\/tox.24217","volume":"39","author":"MS Abdel-Bakky","year":"2024","unstructured":"Abdel-Bakky MS, Mohammed HA, Mahmoud NI, Amin E, Alsharidah M, Al Rugaie O, Ewees MG (2024) Targeting the PI3K \/ pAKT \/ mTOR \/ NF\u2010\u03baB \/ FOXO3a signalling pathway for suppressing the development of hepatocellular carcinoma in rats: Role of the natural remedic Suaeda vermiculata forssk. Environ Toxicol 39:3666\u20133678. https:\/\/doi.org\/10.1002\/tox.24217","journal-title":"Environ Toxicol"},{"key":"4949_CR59","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v14.i3.46","author":"HB Choudhary","year":"2023","unstructured":"Choudhary HB, Mandlik SK, Mandlik DS (2023) Role of p53 suppression in the pathogenesis of hepatocellular carcinoma. World J Gastrointest Pathophysiology Published Online First: 1 June. https:\/\/doi.org\/10.4291\/wjgp.v14.i3.46","journal-title":"World J Gastrointest Pathophysiology Published Online First: 1 June"},{"key":"4949_CR60","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.am2022-2377","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zha Y, Lu H (2022) Abstract 2377: Impairment of p53-activating pathways accelerates liver cancer initiation partially through MTHFD1L-mediated 1\u00a0C metabolism. Cancer Research. Published Online First: 17 June. https:\/\/doi.org\/10.1158\/1538-7445.am2022-2377","journal-title":"Published Online First: 17 June"},{"key":"4949_CR61","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41568-023-00658-3","volume":"24","author":"S Peuget","year":"2024","unstructured":"Peuget S, Zhou X, Selivanova G (2024) Translating p53-based therapies for cancer into the clinic. Nat Rev Cancer 24:192\u2013215. https:\/\/doi.org\/10.1038\/s41568-023-00658-3","journal-title":"Nat Rev Cancer"},{"key":"4949_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-020-0287-y","author":"H Cao","year":"2020","unstructured":"Cao H, Chen X, Wang Z, Wang L, Xia Q, Zhang W (2020) The role of MDM2\u2013p53 axis dysfunction in the hepatocellular carcinoma transformation. Cell Death Discovery Published Online First: 19 June. https:\/\/doi.org\/10.1038\/s41420-020-0287-y","journal-title":"Cell Death Discovery Published Online First: 19 June"},{"key":"4949_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00631","author":"W Li","year":"2020","unstructured":"Li W, Peng X, Lang J, Xu C (2020) Targeting Mouse Double Minute 2: Current Concepts in DNA Damage Repair and Therapeutic Approaches in Cancer. Frontiers in Pharmacology. Published Online First: 7 May. https:\/\/doi.org\/10.3389\/fphar.2020.00631","journal-title":"Published Online First: 7 May"},{"key":"4949_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38430-8","author":"H Yan","year":"2023","unstructured":"Yan H, Wu W, Hu Y et al (2023) Regorafenib inhibits EphA2 phosphorylation and leads to liver damage via the ERK\/MDM2\/p53 axis. Nat Commun Published Online First: 13 May. https:\/\/doi.org\/10.1038\/s41467-023-38430-8","journal-title":"Nat Commun Published Online First: 13 May"},{"key":"4949_CR65","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcancer.2021.03.010","volume":"85","author":"Y Liu","year":"2022","unstructured":"Liu Y, Gu W (2022) The complexity of p53-mediated metabolic regulation in tumour suppression. Sem Cancer Biol 85:4\u201332. https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.010","journal-title":"Sem Cancer Biol"},{"key":"4949_CR66","doi-asserted-by":"publisher","first-page":"432","DOI":"10.3390\/ph13120432","volume":"13","author":"J Cui","year":"2020","unstructured":"Cui J, Shen H-M, Lim LHK (2020) The Role of Autophagy in Liver Cancer: Crosstalk in Signalling Pathways and Potential Therapeutic Targets. Pharmaceuticals 13:432. https:\/\/doi.org\/10.3390\/ph13120432","journal-title":"Pharmaceuticals"},{"key":"4949_CR67","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11538-024-01346-5","volume":"86","author":"R Abukwaik","year":"2024","unstructured":"Abukwaik R, Vera-Siguenza E, Tennant D, Spill F (2024) p53 Orchestrates Cancer Metabolism: Unveiling Strategies to Reverse the Warburg Effect. Bull Math Biol 86:124. https:\/\/doi.org\/10.1007\/s11538-024-01346-5","journal-title":"Bull Math Biol"},{"key":"4949_CR68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jhep.2020.07.036","volume":"74","author":"Y-D Luo","year":"2021","unstructured":"Luo Y-D, Fang L, Yu H-Q et al (2021) p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma. J Hepatol 74:96\u2013108. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.036","journal-title":"J Hepatol"},{"key":"4949_CR69","doi-asserted-by":"publisher","unstructured":"Abdel-Bakky MS, Mohammed HA, Mahmoud NI, Amin E, Alsharidah M, Rugaie OA, Ewees MG (2024) Targeting the PI3K\/pAKT\/mTOR\/NF\u2010\u03baB\/FOXO3a signalling pathway for suppressing the development of hepatocellular carcinoma in rats: Role of the natural remedic Suaeda vermiculata forssk. Environmental Toxicology. Published Online First: 21 March https:\/\/doi.org\/10.1002\/tox.24217","DOI":"10.1002\/tox.24217"},{"key":"4949_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02062-x","author":"X Xu","year":"2021","unstructured":"Xu X, Lei Y, Chen L et al (2021) Phosphorylation of NF-\u03baBp65 drives inflammation-mediated hepatocellular carcinogenesis and is a novel therapeutic target. J Experimental Clin Cancer Res Published Online First: 11 August. https:\/\/doi.org\/10.1186\/s13046-021-02062-x","journal-title":"J Experimental Clin Cancer Res Published Online First: 11 August"},{"key":"4949_CR71","doi-asserted-by":"publisher","unstructured":"Silva-Gomez JA, Galicia-Moreno M, Sandoval-Rodriguez A et al (2021) Hepatocarcinogenesis Prevention by Pirfenidone Is PPAR\u03b3 Mediated and Involves Modification of Nuclear NF-kB p65\/p50 Ratio. International Journal of Molecular Sciences. Published Online First: 21 October https:\/\/doi.org\/10.3390\/ijms222111360","DOI":"10.3390\/ijms222111360"},{"key":"4949_CR72","doi-asserted-by":"publisher","first-page":"6008","DOI":"10.1111\/jcmm.15108","volume":"24","author":"D Zhou","year":"2020","unstructured":"Zhou D, Huang W, Wei J et al (2020) RelB promotes liver fibrosis via inducing the release of injury-associated inflammatory cytokines. J Cell Mol Medi 24:6008\u20136014. https:\/\/doi.org\/10.1111\/jcmm.15108","journal-title":"J Cell Mol Medi"},{"key":"4949_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73387-4","author":"O Waidmann","year":"2020","unstructured":"Waidmann O, Pleli T, Weigert A et al (2020) Tax1BP1 limits hepatic inflammation and reduces experimental hepatocarcinogenesis. Sci Rep Published Online First: 1 Oct. https:\/\/doi.org\/10.1038\/s41598-020-73387-4","journal-title":"Sci Rep Published Online First: 1 Oct"},{"key":"4949_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081053","author":"C Czauderna","year":"2019","unstructured":"Czauderna C, Castven D, Mahn FL, Marquardt JU (2019) Context-Dependent Role of NF-\u03baB Signalling in Primary Liver Cancer\u2014from Tumour Development to Therapeutic Implications. Cancers Published Online First: 25 July. https:\/\/doi.org\/10.3390\/cancers11081053","journal-title":"Cancers Published Online First: 25 July"},{"key":"4949_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-024-01247-3","author":"H-Y Chan","year":"2024","unstructured":"Chan H-Y, Ramasamy TS, Chung FF-L, Teow S-Y (2024) Role of sirtuin 1 (SIRT1) in regulation of autophagy and nuclear factor-kappa Beta (NF-\u0138\u03b2) pathways in sorafenib-resistant hepatocellular carcinoma (HCC). Cell Biochemistry and Biophysics. Published Online First: 12 March. https:\/\/doi.org\/10.1007\/s12013-024-01247-3","journal-title":"Published Online First: 12 March"},{"key":"4949_CR76","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.62347\/ZTGP5030","volume":"17","author":"Y Sun","year":"2025","unstructured":"Sun Y (2025) GLS1 promotes lipid metabolism in hepatocellular carcinoma by regulating the PI3K\/AKT\/mTORC1 signalling pathway through SREBP-1. Am J Transl Res 17:2527\u20132540. https:\/\/doi.org\/10.62347\/ZTGP5030","journal-title":"Am J Transl Res"},{"key":"4949_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1130747","author":"Y Li","year":"2023","unstructured":"Li Y, Wu S, Zhao X et al (2023) Key events in cancer: Dysregulation of SREBPs. Frontiers in Pharmacology. Published Online First: 9 March. https:\/\/doi.org\/10.3389\/fphar.2023.1130747","journal-title":"Published Online First: 9 March"},{"key":"4949_CR78","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-023-10156-5","author":"F Su","year":"2023","unstructured":"Su F, Koeberle A (2023) Regulation and targeting of SREBP-1 in hepatocellular carcinoma. Cancer and Metastasis Reviews. Published Online First: 2 Dec. https:\/\/doi.org\/10.1007\/s10555-023-10156-5","journal-title":"Published Online First: 2 Dec"},{"key":"4949_CR79","doi-asserted-by":"publisher","first-page":"952371","DOI":"10.3389\/fonc.2022.952371","volume":"12","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Lin X, Wang G (2022) Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer. Front Oncol 12:952371. https:\/\/doi.org\/10.3389\/fonc.2022.952371","journal-title":"Front Oncol"},{"key":"4949_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.796152","author":"X Zou","year":"2021","unstructured":"Zou X, Hao J, Zhou X (2021) Inhibition of SREBP-1 Activation by a Novel Small-Molecule Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Tissue to Radiofrequency Ablation. Frontiers in Oncology. Published Online First: 26 November. https:\/\/doi.org\/10.3389\/fonc.2021.796152","journal-title":"Published Online First: 26 November"},{"key":"4949_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107212","author":"R Deng","year":"2024","unstructured":"Deng R, Zhu Y, Liu K, Zhang Q, Hu S, Wang M, Zhang Y (2024) Genetic loss of Nrf1 and Nrf2 leads to distinct metabolism reprogramming of HepG2 cells by opposing regulation of the PI3K-AKT-mTOR signalling pathway. Bioorg Chem Published Online First: 1 April. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107212","journal-title":"Bioorg Chem Published Online First: 1 April"},{"key":"4949_CR82","doi-asserted-by":"publisher","first-page":"107037","DOI":"10.1016\/j.phrs.2023.107037","volume":"199","author":"S Shen","year":"2024","unstructured":"Shen S, Shen M, Kuang L et al (2024) SIRT1\/SREBPs-mediated regulation of lipid metabolism. Pharmacol Res 199:107037. https:\/\/doi.org\/10.1016\/j.phrs.2023.107037","journal-title":"Pharmacol Res"},{"key":"4949_CR83","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/antiox11050911","volume":"11","author":"J-P Shiau","year":"2022","unstructured":"Shiau J-P, Chuang Y-T, Cheng Y-B, Tang J-Y, Hou M-F, Yen C-Y, Chang H-W (2022) Impacts of Oxidative Stress and PI3K\/AKT\/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism. Antioxidants 11:911. https:\/\/doi.org\/10.3390\/antiox11050911","journal-title":"Antioxidants"},{"key":"4949_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.05.011","author":"ED Dean","year":"2017","unstructured":"Dean ED, Li M, Prasad N et al (2017) Interrupted Glucagon Signalling Reveals Hepatic \u03b1 Cell Axis and Role for L-Glutamine in \u03b1 Cell Proliferation. Cell Metabolism Published Online First: 1 June. https:\/\/doi.org\/10.1016\/j.cmet.2017.05.011","journal-title":"Cell Metabolism Published Online First: 1 June"},{"key":"4949_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31310","author":"X Lu","year":"2020","unstructured":"Lu X, Paliogiannis P, Calvisi DF, Chen X (2020) Role of the Mammalian Target of Rapamycin Pathway in Liver Cancer: From Molecular Genetics to Targeted Therapies. Hepatology. Published Online First: 3 Dec. https:\/\/doi.org\/10.1002\/hep.31310","journal-title":"Published Online First: 3 Dec"},{"key":"4949_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1828-2","author":"T Li","year":"2019","unstructured":"Li T, Weng J, Zhang Y et al (2019) mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma. Cell Death Disease Published Online First: 1 August. https:\/\/doi.org\/10.1038\/s41419-019-1828-2","journal-title":"Cell Death Disease Published Online First: 1 August"},{"key":"4949_CR87","doi-asserted-by":"publisher","unstructured":"Shiau J-P, Chuang Y-T, Cheng Y-B, Tang J-Y, Hou M-F, Yen C-Y, Chang H-W (2022) Impacts of Oxidative Stress and PI3K\/AKT\/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism. Antioxidants. Published Online First: 7 May https:\/\/doi.org\/10.3390\/antiox11050911","DOI":"10.3390\/antiox11050911"},{"key":"4949_CR88","doi-asserted-by":"publisher","unstructured":"Narayanankutty A, Nambiattil S, Mannarakkal S Phytochemicals and Nanoparticles in the Modulation of PI3K\/Akt\/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence. Recent Patents on Anti-Cancer Drug Discovery. 18:307\u2013324. https:\/\/doi.org\/10.2174\/1574892817666220606104712","DOI":"10.2174\/1574892817666220606104712"},{"key":"4949_CR89","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/mnfr.201100454","volume":"55","author":"J-C Wu","year":"2011","unstructured":"Wu J-C, Lai C-S, Badmaev V, Nagabhushanam K, Ho C-T, Pan M-H (2011) Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K\/Akt-mTOR and MAPK signalling pathways in human leukemia HL-60 cells. Mol Nutr Food Res 55:1646\u20131654. https:\/\/doi.org\/10.1002\/mnfr.201100454","journal-title":"Mol Nutr Food Res"},{"key":"4949_CR90","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16081554","author":"V Zoi","year":"2024","unstructured":"Zoi V, Kyritsis AP, Galani V, Lazari D, Sioka C, Voulgaris S, Alexiou GA (2024) The Role of Curcumin in Cancer: A Focus on the PI3K\/Akt Pathway. Cancers. Published Online First: 19 April. https:\/\/doi.org\/10.3390\/cancers16081554","journal-title":"Published Online First: 19 April"},{"key":"4949_CR91","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.5805","author":"J Wang","year":"2018","unstructured":"Wang J, Wang C, Bu G (2018) Curcumin inhibits the growth of liver cancer stem cells through the phosphatidylinositol 3-kinase\/protein kinase B\/mammalian target of rapamycin signalling pathway. Experimental Therapeutic Med Published Online First: 29 January. https:\/\/doi.org\/10.3892\/etm.2018.5805","journal-title":"Experimental Therapeutic Med Published Online First: 29 January"},{"key":"4949_CR92","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.1080\/87559129.2022.2067173","volume":"39","author":"N Sanlier","year":"2023","unstructured":"Sanlier N, Kocabas \u015e, Erdogan K, Sanlier NT (2023) Effects of curcumin, its analogues, and metabolites on various cancers: focusing on potential mechanisms. Food Reviews Int 39:5356\u20135376. https:\/\/doi.org\/10.1080\/87559129.2022.2067173","journal-title":"Food Reviews Int"},{"key":"4949_CR93","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3126\/medphoenix.v2i1.18388","volume":"2","author":"M Ahmad","year":"2017","unstructured":"Ahmad M, Mishra A, Usmani A, Ahmad MP (2017) Dietary Agents and Phytochemicals in the Prevention and Treatment of Hepatocellular Carcinoma: Review Article. Med Phoenix 2:52\u201362. https:\/\/doi.org\/10.3126\/medphoenix.v2i1.18388","journal-title":"Med Phoenix"},{"key":"4949_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ph14111068","author":"A Arena","year":"2021","unstructured":"Arena A, Romeo MA, Benedetti R, Masuelli L, Bei R, Montani MSG, Cirone M (2021) New Insights into Curcumin- and Resveratrol-Mediated Anti-Cancer Effects. Pharmaceuticals Published Online First: 22 Oct. https:\/\/doi.org\/10.3390\/ph14111068","journal-title":"Pharmaceuticals Published Online First: 22 Oct"},{"key":"4949_CR95","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8043","author":"Q Hu","year":"2023","unstructured":"Hu Q, Zhang W, Wei F et al (2023) Human diet-derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization. Phytotherapy Res Published Online First: 24 Oct. https:\/\/doi.org\/10.1002\/ptr.8043","journal-title":"Phytotherapy Res Published Online First: 24 Oct"},{"key":"4949_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117481","author":"M Mirza-Aghazadeh-Attari","year":"2020","unstructured":"Mirza-Aghazadeh-Attari M, Ekrami EM, Aghdas SAM et al (2020) Targeting PI3K\/Akt\/mTOR signalling pathway by polyphenols: Implication for cancer therapy. Life Sci Published Online First: 1 August. https:\/\/doi.org\/10.1016\/j.lfs.2020.117481","journal-title":"Life Sci Published Online First: 1 August"},{"key":"4949_CR97","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12094-021-02709-3","volume":"24","author":"A Hazafa","year":"2022","unstructured":"Hazafa A, Iqbal MO, Javaid U et al (2022) Inhibitory effect of polyphenols (phenolic acids, lignans, and stilbenes) on cancer by regulating signal transduction pathways: a review. Clin Transl Oncol 24:432\u2013445. https:\/\/doi.org\/10.1007\/s12094-021-02709-3","journal-title":"Clin Transl Oncol"},{"key":"4949_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27123816","author":"Y Yoshioka","year":"2022","unstructured":"Yoshioka Y, Ohishi T, Nakamura Y, Fukutomi R, Miyoshi N (2022) Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs. Molecules Published Online First: 15 June. https:\/\/doi.org\/10.3390\/molecules27123816","journal-title":"Molecules Published Online First: 15 June"},{"key":"4949_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/app112110077","author":"ES Scarpa","year":"2021","unstructured":"Scarpa ES, Giammanco M, Magnani M (2021) Gastrointestinal Tumours: Phytochemical and Drug Combinations Targeting the Hallmarks of Cancer. Appl Sci Published Online First: 27 Oct. https:\/\/doi.org\/10.3390\/app112110077","journal-title":"Appl Sci Published Online First: 27 Oct"},{"key":"4949_CR100","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.2174\/0929867327666200228110738","volume":"28","author":"C Naujokat","year":"2021","unstructured":"Naujokat C, McKee DL (2021) The Big Five Phytochemicals Targeting Cancer Stem Cells: Curcumin, EGCG, Sulforaphane, Resveratrol and Genistein. CMC 28:4321\u20134342. https:\/\/doi.org\/10.2174\/0929867327666200228110738","journal-title":"CMC"},{"key":"4949_CR101","doi-asserted-by":"publisher","DOI":"10.1002\/mc.22718","author":"H-H Zhang","year":"2017","unstructured":"Zhang H-H, Zhang Y, Cheng Y-N, Gong F-L, Cao Z-Q, Yu L-G, Guo X-L (2017) Metformin incombination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivo. Mol Carcinog Published Online First: 12 September. https:\/\/doi.org\/10.1002\/mc.22718","journal-title":"Mol Carcinog Published Online First: 12 September"},{"key":"4949_CR102","doi-asserted-by":"publisher","unstructured":"Li S, Tan HY, Wang N, Cheung F, Hong M, Feng Y (January 2018) The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases. Oxidative Medicine and Cellular Longevity. Published Online First: 1. https:\/\/doi.org\/10.1155\/2018\/8394818","DOI":"10.1155\/2018\/8394818"},{"key":"4949_CR103","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.chmed.2022.06.007","volume":"14","author":"Z Li","year":"2022","unstructured":"Li Z, Hao E, Cao R et al (2022) Analysis on internal mechanism of zedoary turmeric in treatment of liver cancer based on pharmacodynamic substances and pharmacodynamic groups. Chin Herb Med 14:479\u2013493. https:\/\/doi.org\/10.1016\/j.chmed.2022.06.007","journal-title":"Chin Herb Med"},{"key":"4949_CR104","doi-asserted-by":"publisher","first-page":"1116532","DOI":"10.3389\/fonc.2023.1116532","volume":"13","author":"Y Wang","year":"2023","unstructured":"Wang Y, Li J, Xia L (2023) Plant-derived natural products and combination therapy in liver cancer. Front Oncol 13:1116532. https:\/\/doi.org\/10.3389\/fonc.2023.1116532","journal-title":"Front Oncol"},{"key":"4949_CR105","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3892\/or.2017.5347","volume":"37","author":"F Gao","year":"2017","unstructured":"Gao F, Deng G, Liu W, Zhou K, Li M (2017) Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signalling pathway. Oncol Rep 37:1203\u20131211. https:\/\/doi.org\/10.3892\/or.2017.5347","journal-title":"Oncol Rep"},{"key":"4949_CR106","doi-asserted-by":"publisher","first-page":"112852","DOI":"10.1016\/j.jep.2020.112852","volume":"259","author":"Z-H Liao","year":"2020","unstructured":"Liao Z-H, Zhu H-Q, Chen Y-Y et al (2020) The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK\/ERK1\/2 and PI3K\/AKT\/ HIF-1\u03b1\/VEGF dependent pathways. J Ethnopharmacol 259:112852. https:\/\/doi.org\/10.1016\/j.jep.2020.112852","journal-title":"J Ethnopharmacol"},{"key":"4949_CR107","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3892\/ijo.2014.2251","volume":"44","author":"X Shen","year":"2014","unstructured":"Shen X, Zhang Y, Feng Y, Zhang L, Li J, Xie Y-A, Luo X (2014) Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway. Int J Oncol 44:791\u2013796. https:\/\/doi.org\/10.3892\/ijo.2014.2251","journal-title":"Int J Oncol"},{"key":"4949_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.710304","author":"MH Ch\u00e1irez-Ram\u00edrez","year":"2021","unstructured":"Ch\u00e1irez-Ram\u00edrez MH, Cruz-L\u00f3pez KG, Garc\u00eda-Carranc\u00e1 A (2021) Polyphenols as Antitumour Agents Targeting Key Players in Cancer-Driving Signalling Pathways. Frontiers in Pharmacology. Published Online First: 20 Oct. https:\/\/doi.org\/10.3389\/fphar.2021.710304","journal-title":"Published Online First: 20 Oct"},{"key":"4949_CR109","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02333-5","author":"MR Islam","year":"2024","unstructured":"Islam MR, Rauf A, Alash S et al (2024) A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signalling pathways. Med Oncol Published Online First: 9 May. https:\/\/doi.org\/10.1007\/s12032-024-02333-5","journal-title":"Med Oncol Published Online First: 9 May"},{"key":"4949_CR110","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.33710","author":"M Wang","year":"2019","unstructured":"Wang M, Jiang S, Zhou L et al (2019) Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signalling Pathways and miRNAs. Int J Biol Sci Published Online First: 1 January. https:\/\/doi.org\/10.7150\/ijbs.33710","journal-title":"Int J Biol Sci Published Online First: 1 January"},{"key":"4949_CR111","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030562","author":"C Kiruthiga","year":"2020","unstructured":"Kiruthiga C, Devi KP, Nabavi SM, Bishayee A (2020) Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma. Cancers Published Online First: 29 Febr. https:\/\/doi.org\/10.3390\/cancers12030562","journal-title":"Cancers Published Online First: 29 Febr"},{"key":"4949_CR112","doi-asserted-by":"publisher","unstructured":"Huang J, Feng W, Li S et al (2021) Berberine Exerts Anti-cancer Activity by Modulating Adenosine Monophosphate- Activated Protein Kinase (AMPK) and the Phosphatidylinositol 3-Kinase\/ Protein Kinase B (PI3K\/AKT) Signalling Pathways. Current Pharmaceutical Design. Published Online First: 3 March https:\/\/doi.org\/10.2174\/1381612826666200928155728","DOI":"10.2174\/1381612826666200928155728"},{"key":"4949_CR113","doi-asserted-by":"publisher","unstructured":"Jian Q, Shu Y, Li Z et al (2025) Berberine Hydrochloride Inhibits the Proliferation and Tumourigenesis of Hepatocellular Carcinoma Cells by Regulating Amino Acid Metabolism. ACAMC 25. https:\/\/doi.org\/10.2174\/0118715206357856241223095321","DOI":"10.2174\/0118715206357856241223095321"},{"key":"4949_CR114","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27185889","author":"SA Almatroodi","year":"2022","unstructured":"Almatroodi SA, Alsahli MA, Rahmani AH (2022) Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signalling Pathways. Molecules Published Online First: 11 September. https:\/\/doi.org\/10.3390\/molecules27185889","journal-title":"Molecules Published Online First: 11 September"},{"key":"4949_CR115","doi-asserted-by":"publisher","DOI":"10.1177\/1934578x221102032","author":"Y Liu","year":"2022","unstructured":"Liu Y, Nwafor E-O, Li Z et al (2022) Effects of Berberine on Liver Cancer. Natural Product Communications. Published Online First: 1 May. https:\/\/doi.org\/10.1177\/1934578x221102032","journal-title":"Published Online First: 1 May"},{"key":"4949_CR116","doi-asserted-by":"publisher","first-page":"11810","DOI":"10.3390\/app112411810","volume":"11","author":"K Mustafa","year":"2021","unstructured":"Mustafa K, Yu S, Mohamed H et al (2021) Comparative Study on the Role of Berberine and Berberis lycium Royle Roots Extract against the Biochemical Markers and Cyclin D1 Expression in HCC Animal Model. Appl Sci 11:11810. https:\/\/doi.org\/10.3390\/app112411810","journal-title":"Appl Sci"},{"key":"4949_CR117","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7181","author":"S Bansod","year":"2021","unstructured":"Bansod S, Saifi MA, Godugu C (2021) Molecular updates on berberine in liver diseases: Bench to bedside. Phytotherapy Research. Published Online First: 31 May. https:\/\/doi.org\/10.1002\/ptr.7181","journal-title":"Published Online First: 31 May"},{"key":"4949_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/tox.24041","author":"X Chang","year":"2023","unstructured":"Chang X, Li H, Huang Z, Song C, Zhang Z, Pan W (2023) Matrine suppresses hepatocellular carcinoma tumourigenesis by modulating circ_0055976\/miR-1179\/lactate dehydrogenase A axis. Environ Toxicol Published Online First: 23 November. https:\/\/doi.org\/10.1002\/tox.24041","journal-title":"Environ Toxicol Published Online First: 23 November"},{"key":"4949_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23436","author":"Z Huang","year":"2023","unstructured":"Huang Z, Li H, Li Q, Chen X, Liu R, Chang X (2023) Matrine suppresses liver cancer progression and the Warburg effect by regulating the circROBO1\/miR-130a\u20105p\/ROBO1 axis. J Biochem Mol Toxicol Published Online First: 29 June. https:\/\/doi.org\/10.1002\/jbt.23436","journal-title":"J Biochem Mol Toxicol Published Online First: 29 June"},{"key":"4949_CR120","doi-asserted-by":"publisher","unstructured":"Song C, Li H, Huang Z, Chang X, Pan W, Zhang Z (2024) Matrine inhibits cell proliferation, invasion, and stem cell formation in hepatocellular carcinoma by regulating the ELAVL1\/RBM3-mediated Wnt\/\u03b2\u2010catenin signalling pathway. Chemical Biology & Drug Design. Published Online First: 24 January https:\/\/doi.org\/10.1111\/cbdd.14442","DOI":"10.1111\/cbdd.14442"},{"key":"4949_CR121","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1080\/14756366.2022.2118268","volume":"37","author":"J Chen","year":"2022","unstructured":"Chen J, Duan Y, Yu X et al (2022) Development of novel 9- O -substituted-13-octylberberine derivatives as potential anti-hepatocellular carcinoma agents. J Enzyme Inhib Med Chem 37:2423\u20132433. https:\/\/doi.org\/10.1080\/14756366.2022.2118268","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4949_CR122","doi-asserted-by":"publisher","first-page":"15991","DOI":"10.3390\/ijms232415991","volume":"23","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang S, Han K, Wang L, Liu X (2022) Induction of Apoptosis by Matrine Derivative ZS17 in Human Hepatocellular Carcinoma BEL-7402 and HepG2 Cells through ROS-JNK-P53 Signalling Pathway Activation. IJMS 23:15991. https:\/\/doi.org\/10.3390\/ijms232415991","journal-title":"IJMS"},{"key":"4949_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/s12870-025-06807-0","author":"X Wang","year":"2025","unstructured":"Wang X, Wan X, Zhu T, Cui L, Xiao Q (2025) Metabolomics combined with network pharmacology reveals the anti-hepatoma effects of terpenoids from Polygonatum kingianum var. grandifolium and Polygonatum sibiricum Redout\u00e9 as well as differences in their terpenoid metabolites. BMC Plant Biology Published Online First: 5 June. https:\/\/doi.org\/10.1186\/s12870-025-06807-0","journal-title":"BMC Plant Biology Published Online First: 5 June"},{"key":"4949_CR124","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13559","author":"OA Akinloye","year":"2020","unstructured":"Akinloye OA, Akinloye DI, Lawal MA, Shittu MT, Metibemu DS (2020) Terpenoids from Azadirachta indica are potent inhibitors of Akt: Validation of the anticancer potentials in hepatocellular carcinoma in male Wistar rats. J Food Biochem Published Online First: 15 November. https:\/\/doi.org\/10.1111\/jfbc.13559","journal-title":"J Food Biochem Published Online First: 15 November"},{"key":"4949_CR125","doi-asserted-by":"publisher","first-page":"104101","DOI":"10.1016\/j.phytol.2025.104101","volume":"71","author":"Z-X Jiang","year":"2026","unstructured":"Jiang Z-X, Feng J, Hou W-C, Wang M-R, Zhang S-N, Liang H-J, Liu Y-Y (2026) Bioinformatics-based discovery of a new norsesquiterpenoid from agarwood targeting CHRM2 and regulating the PI3K-Akt pathway in liver cancer. Phytochem Lett 71:104101. https:\/\/doi.org\/10.1016\/j.phytol.2025.104101","journal-title":"Phytochem Lett"},{"key":"4949_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.02.035","author":"YA Nevzorova","year":"2017","unstructured":"Nevzorova YA, Grossmann J, Trautwein C (2017) Anti-tumourigenic and anti-angiogenic effects of natural conifer Abies sibirica terpenoids in vivo and in vitro. Biomedicine & Pharmacotherapy. Published Online First: 1 May. https:\/\/doi.org\/10.1016\/j.biopha.2017.02.035","journal-title":"Published Online First: 1 May"},{"key":"4949_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2023.03.006","author":"L Qu","year":"2023","unstructured":"Qu L, Liu Y, Deng J, Ma X, Fan D (2023) Ginsenoside Rk3 is a novel PI3K\/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma. J Pharm Anal Published Online First: 26 March. https:\/\/doi.org\/10.1016\/j.jpha.2023.03.006","journal-title":"J Pharm Anal Published Online First: 26 March"},{"key":"4949_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106306","author":"H Li","year":"2022","unstructured":"Li H, Yu Y, Liu Y et al (2022) Ursolic acid enhances the antitumour effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer. Pharmacol Res Published Online First: 1 August. https:\/\/doi.org\/10.1016\/j.phrs.2022.106306","journal-title":"Pharmacol Res Published Online First: 1 August"},{"key":"4949_CR129","doi-asserted-by":"publisher","first-page":"103054","DOI":"10.1016\/j.bioorg.2019.103054","volume":"90","author":"G Fontana","year":"2019","unstructured":"Fontana G, Bruno M, Notarbartolo M, Labbozzetta M, Poma P, Spinella A, Rosselli S (2019) Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-\u03baB involvement. Bioorg Chem 90:103054. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103054","journal-title":"Bioorg Chem"},{"key":"4949_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2024.104460","author":"M Dong","year":"2024","unstructured":"Dong M, Cui Q, Li Y et al (2024) Ursolic acid suppresses fatty liver-associated hepatocellular carcinoma by regulating lipid metabolism. Food Bioscience Published Online First: 1 August. https:\/\/doi.org\/10.1016\/j.fbio.2024.104460","journal-title":"Food Bioscience Published Online First: 1 August"},{"key":"4949_CR131","doi-asserted-by":"publisher","DOI":"10.1039\/d1nj05294b","author":"W-Y Wang","year":"2022","unstructured":"Wang W-Y, Yang Z-H, Li A-L, Liu Q-S, Sun Y, Gu W (2022) Design, synthesis, anticancer activity and mechanism studies of novel 2-amino-4-aryl-pyrimidine derivatives of ursolic acid. New J Chem Published Online First: 1 January. https:\/\/doi.org\/10.1039\/d1nj05294b","journal-title":"New J Chem Published Online First: 1 January"},{"key":"4949_CR132","doi-asserted-by":"publisher","first-page":"104705","DOI":"10.1016\/j.bioorg.2021.104705","volume":"109","author":"W-Y Wang","year":"2021","unstructured":"Wang W-Y, Wu W-Y, Li A-L, Liu Q-S, Sun Y, Gu W (2021) Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acid. Bioorg Chem 109:104705. https:\/\/doi.org\/10.1016\/j.bioorg.2021.104705","journal-title":"Bioorg Chem"},{"key":"4949_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.11.014","author":"H Dong","year":"2015","unstructured":"Dong H, Yang X, Xie J et al (2015) UP12, a novel ursolic acid derivative with potential for targeting multiple signalling pathways in hepatocellular carcinoma. Biochem Pharmacol Published Online First: 1 January. https:\/\/doi.org\/10.1016\/j.bcp.2014.11.014","journal-title":"Biochem Pharmacol Published Online First: 1 January"},{"key":"4949_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.comtox.2023.100281","author":"OI Olaposi","year":"2023","unstructured":"Olaposi OI, Oyekanmi N, Samuel MD, Chiamaka IG, Olatunji OM, Agbebi E, Olufunke FC (2023) Dihydroartemisinin Binds Human PI3K-Affinity Pocket and Forces Flat Conformation In P-loop MET: A Molecular Dynamics Study. Computational Toxicology. Published Online First: 1 June. https:\/\/doi.org\/10.1016\/j.comtox.2023.100281","journal-title":"Published Online First: 1 June"},{"key":"4949_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.599067","author":"T-E Huang","year":"2020","unstructured":"Huang T-E, Deng Y-N, Hsu J-L et al (2020) Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells. Frontiers in Pharmacology. Published Online First: 10 November. https:\/\/doi.org\/10.3389\/fphar.2020.599067","journal-title":"Published Online First: 10 November"},{"key":"4949_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29163886","author":"L Wen","year":"2024","unstructured":"Wen L, Chan BC-L, Qiu M-H, Leung P-C, Wong C-K (2024) Artemisinin and Its Derivatives as Potential Anticancer Agents. Molecules Published Online First: 18 August. https:\/\/doi.org\/10.3390\/molecules29163886","journal-title":"Molecules Published Online First: 18 August"},{"key":"4949_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2019.08.115","author":"W Jing","year":"2019","unstructured":"Jing W, Shuo L, Yingru X, Min M, Runpeng Z, Jun X, Dong H (2019) Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. Published Online First: 1 Oct. https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.115","journal-title":"Published Online First: 1 Oct"},{"key":"4949_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.smaim.2023.08.003","author":"K Liu","year":"2023","unstructured":"Liu K, Chen K, Zhang X et al (2023) Potentiating sorafenib efficacy against hepatocellular carcinoma via a carrier-free nanomedicine of artesunate prodrug. Smart Mater Med Published Online First: 14 Oct. https:\/\/doi.org\/10.1016\/j.smaim.2023.08.003","journal-title":"Smart Mater Med Published Online First: 14 Oct"},{"key":"4949_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.04.072","author":"J Yang","year":"2018","unstructured":"Yang J, Pi C, Wang G (2018) Inhibition of PI3K\/Akt\/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Biomed Pharmacotherapy Published Online First: 1 July. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.072","journal-title":"Biomed Pharmacotherapy Published Online First: 1 July"},{"key":"4949_CR140","doi-asserted-by":"publisher","unstructured":"Meng X, Li M, Qiao M, Li X, Yang J, Hu J Hugan Buzure Induces Autophagy and Apoptosis in Hepatocellular Carcinoma by Inhibiting PI3K\/Akt\/mTOR Signalling Pathway. Evidence-based Complementary and Alternative Medicine. Published Online First: 21 December 2022. https:\/\/doi.org\/10.1155\/2022\/1618491","DOI":"10.1155\/2022\/1618491"},{"key":"4949_CR141","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3390\/ijms24032652","volume":"24","author":"L-Y Tian","year":"2023","unstructured":"Tian L-Y, Smit DJ, J\u00fccker M (2023) The Role of PI3K\/AKT\/mTOR Signalling in Hepatocellular Carcinoma Metabolism. IJMS 24:2652. https:\/\/doi.org\/10.3390\/ijms24032652","journal-title":"IJMS"},{"key":"4949_CR142","doi-asserted-by":"publisher","DOI":"10.2174\/1874467214666210120152657","author":"A Narayanankutty","year":"2021","unstructured":"Narayanankutty A (2021) Natural Products as PI3K\/ Akt Inhibitors: Implications in Preventing Hepatocellular Carcinoma. Curr Mol Pharmacol Published Online First: 16 Dec. https:\/\/doi.org\/10.2174\/1874467214666210120152657","journal-title":"Curr Mol Pharmacol Published Online First: 16 Dec"},{"key":"4949_CR143","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.biopha.2018.04.072","volume":"103","author":"J Yang","year":"2018","unstructured":"Yang J, Pi C, Wang G (2018) Inhibition of PI3K\/Akt\/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells. Biomed Pharmacother 103:699\u2013707. https:\/\/doi.org\/10.1016\/j.biopha.2018.04.072","journal-title":"Biomed Pharmacother"},{"key":"4949_CR144","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b20-00030","author":"P-L Zhu","year":"2020","unstructured":"Zhu P-L, Lam DF, Li J-K et al (2020) Gomisin N Exerts Anti-liver Cancer Effects and Regulates PI3K\u2013Akt and mTOR\u2013ULK1 Pathways in Vitro. Biological and Pharmaceutical Bulletin. Published Online First: 1 August. https:\/\/doi.org\/10.1248\/bpb.b20-00030","journal-title":"Published Online First: 1 August"},{"key":"4949_CR145","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2020.1836241","author":"K Sundarraj","year":"2020","unstructured":"Sundarraj K, Raghunath A, Panneerselvam L, Perumal E (2020) Fisetin Inhibits Autophagy in HepG2 Cells via PI3K\/Akt\/mTOR and AMPK Pathway. Nutrition and Cancer. Published Online First: 21 Oct. https:\/\/doi.org\/10.1080\/01635581.2020.1836241","journal-title":"Published Online First: 21 Oct"},{"key":"4949_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120895","author":"Y Song","year":"2025","unstructured":"Song Y, Tian S, Zhang X et al (2025) Total flavonoids of Prunella vulgaris exert anti\u2013hepatocellular carcinoma effects through autophagy suppression mediated by activation of the PI3K\/AKT\/mTOR pathway. J Ethnopharmacol Published Online First: 13 November. https:\/\/doi.org\/10.1016\/j.jep.2025.120895","journal-title":"J Ethnopharmacol Published Online First: 13 November"},{"key":"4949_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115615","author":"J Man","year":"2023","unstructured":"Man J, Zhou W, Zuo S, Zhao X, Wang Q, Ma H, Li H-Y (2023) TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K\/AKT\/mTOR signalling pathway. Biochemical Pharmacology. Published Online First: 20 May. https:\/\/doi.org\/10.1016\/j.bcp.2023.115615","journal-title":"Published Online First: 20 May"},{"key":"4949_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.bspc.2022.103554","author":"Y Peng","year":"2022","unstructured":"Peng Y, Yang J, Li Z, Chen S, Tang X, Zhou J (2022) Overexpression of SLC40A1 inhibits the malignancy of hepatocellular carcinoma MHCC-97H cells by stimulation of autophagy. Biomedical Signal Process Control Published Online First: 1 May. https:\/\/doi.org\/10.1016\/j.bspc.2022.103554","journal-title":"Biomedical Signal Process Control Published Online First: 1 May"},{"key":"4949_CR149","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-018-0843-8","volume":"17","author":"X Xin","year":"2018","unstructured":"Xin X, Wu M, Meng Q et al (2018) Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a. Mol Cancer 17:94. https:\/\/doi.org\/10.1186\/s12943-018-0843-8","journal-title":"Mol Cancer"},{"key":"4949_CR150","doi-asserted-by":"publisher","unstructured":"Li Y, Yan W, Qin Y, Zhang L, Xiao S (2024) IJMS, Vol. 25, Pages 6468: The Anthraquinone Derivative C2 Enhances Oxaliplatin-Induced Cell Death and Triggers Autophagy via the PI3K\/AKT\/mTOR Pathway. International Journal of Molecular Sciences. Published Online First: 13 June https:\/\/doi.org\/10.3390\/ijms25126468","DOI":"10.3390\/ijms25126468"},{"key":"4949_CR151","doi-asserted-by":"publisher","first-page":"2300211","DOI":"10.1002\/bies.202300211","volume":"46","author":"D Kim","year":"2024","unstructured":"Kim D (2024) Contrasting views on the role of AMPK in autophagy. BioEssays 46:2300211. https:\/\/doi.org\/10.1002\/bies.202300211","journal-title":"BioEssays"},{"key":"4949_CR152","doi-asserted-by":"publisher","unstructured":"Tian L-Y, Smit DJ, J\u00fccker M (2023) IJMS, Vol. 24, Pages 2652: The Role of PI3K\/AKT\/mTOR Signalling in Hepatocellular Carcinoma Metabolism. International Journal of Molecular Sciences. Published Online First: 31 January https:\/\/doi.org\/10.3390\/ijms24032652","DOI":"10.3390\/ijms24032652"},{"key":"4949_CR153","doi-asserted-by":"publisher","first-page":"596655","DOI":"10.3389\/fcell.2020.596655","volume":"8","author":"H-Y Lai","year":"2021","unstructured":"Lai H-Y, Tsai H-H, Yen C-J et al (2021) Metformin Resensitizes Sorafenib-Resistant HCC Cells Through AMPK-Dependent Autophagy Activation. Front Cell Dev Biol 8:596655. https:\/\/doi.org\/10.3389\/fcell.2020.596655","journal-title":"Front Cell Dev Biol"},{"key":"4949_CR154","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s257966","author":"C Gao","year":"2020","unstructured":"Gao C, Fang L, Zhang H, Zhang W-S, Li X-O, Du S-Y (2020) Metformin Induces Autophagy via the AMPK-mTOR Signalling Pathway in Human Hepatocellular Carcinoma Cells. Cancer Management and Research. Published Online First: 1 July. https:\/\/doi.org\/10.2147\/cmar.s257966","journal-title":"Published Online First: 1 July"},{"key":"4949_CR155","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0308-4","author":"X Yang","year":"2018","unstructured":"Yang X, Liu Y, Li M et al (2018) Predictive and preventive significance of AMPK activation on hepatocarcinogenesis in patients with liver cirrhosis. Cell Death Disease Published Online First: 15 Febr. https:\/\/doi.org\/10.1038\/s41419-018-0308-4","journal-title":"Cell Death Disease Published Online First: 15 Febr"},{"key":"4949_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11120811","author":"X Yin","year":"2021","unstructured":"Yin X, Li W, Zhang J et al (2021) AMPK-Mediated Metabolic Switching Is High Effective for Phytochemical Levo-Tetrahydropalmatine (l-THP) to Reduce Hepatocellular Carcinoma Tumour Growth. Metabolites. Published Online First: 29 November. https:\/\/doi.org\/10.3390\/metabo11120811","journal-title":"Published Online First: 29 November"},{"key":"4949_CR157","doi-asserted-by":"publisher","first-page":"106219","DOI":"10.1016\/j.phrs.2022.106219","volume":"179","author":"X Yin","year":"2022","unstructured":"Yin X, Zhang J, Zhao W, Liu Z, Wang J (2022) Combined Levo-tetrahydropalmatine and diphenyleneiodonium chloride enhances antitumour activity in hepatocellular carcinoma. Pharmacol Res 179:106219. https:\/\/doi.org\/10.1016\/j.phrs.2022.106219","journal-title":"Pharmacol Res"},{"key":"4949_CR158","doi-asserted-by":"publisher","first-page":"114587","DOI":"10.1016\/j.fct.2024.114587","volume":"186","author":"H Wu","year":"2024","unstructured":"Wu H, Qu L, Bai X et al (2024) Ginsenoside Rk1 induces autophagy-dependent apoptosis in hepatocellular carcinoma by AMPK\/mTOR signalling pathway. Food Chem Toxicol 186:114587. https:\/\/doi.org\/10.1016\/j.fct.2024.114587","journal-title":"Food Chem Toxicol"},{"key":"4949_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72309-y","author":"F Hidalgo","year":"2024","unstructured":"Hidalgo F, Ferretti AC, Etichetti CB et al (2024) Alpha lipoic acid diminishes migration and invasion in hepatocellular carcinoma cells through an AMPK-p53 axis. Sci Rep Published Online First: 13 September. https:\/\/doi.org\/10.1038\/s41598-024-72309-y","journal-title":"Sci Rep Published Online First: 13 September"},{"key":"4949_CR160","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-024-01314-5","author":"X Yu","year":"2024","unstructured":"Yu X, Feng M, Guo J et al (2024) MLKL promotes hepatocarcinogenesis through inhibition of AMPK-mediated autophagy. Cell Death Differ Published Online First: 24 May. https:\/\/doi.org\/10.1038\/s41418-024-01314-5","journal-title":"Cell Death Differ Published Online First: 24 May"},{"key":"4949_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101154","author":"Y Ren","year":"2019","unstructured":"Ren Y, Shen H-M (2019) Critical role of AMPK in redox regulation under glucose starvation. Redox Biology Published Online First: 1 July. https:\/\/doi.org\/10.1016\/j.redox.2019.101154","journal-title":"Redox Biology Published Online First: 1 July"},{"key":"4949_CR162","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10735-024-10191-8","volume":"55","author":"MM-T Wong","year":"2024","unstructured":"Wong MM-T, Aziz NA, Ch\u2019ng ES et al (2024) Expression of LC3A, LC3B and p62\/SQSTM1 autophagy proteins in hepatocellular carcinoma (HCC) tissues and the predicted microRNAs involved in the autophagy-related pathway. J Mol Histol 55:317\u2013328. https:\/\/doi.org\/10.1007\/s10735-024-10191-8","journal-title":"J Mol Histol"},{"key":"4949_CR163","doi-asserted-by":"publisher","first-page":"4566","DOI":"10.3390\/cancers15184566","volume":"15","author":"A Kakehashi","year":"2023","unstructured":"Kakehashi A, Suzuki S, Wanibuchi H (2023) Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis. Cancers 15:4566. https:\/\/doi.org\/10.3390\/cancers15184566","journal-title":"Cancers"},{"key":"4949_CR164","doi-asserted-by":"publisher","first-page":"11770","DOI":"10.3390\/ijms222111770","volume":"22","author":"F Fondevila","year":"2021","unstructured":"Fondevila F, M\u00e9ndez-Blanco C, Fern\u00e1ndez-Palanca P et al (2021) Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib. IJMS 22:11770. https:\/\/doi.org\/10.3390\/ijms222111770","journal-title":"IJMS"},{"key":"4949_CR165","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s10571-015-0318-z","volume":"36","author":"X Liu","year":"2016","unstructured":"Liu X, Sun K, Wang H, Dai Y (2016) Inhibition of Autophagy by Chloroquine Enhances the Antitumour Efficacy of Sorafenib in Glioblastoma. Cell Mol Neurobiol 36:1197\u20131208. https:\/\/doi.org\/10.1007\/s10571-015-0318-z","journal-title":"Cell Mol Neurobiol"},{"key":"4949_CR166","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3390\/biomedicines14010212","volume":"14","author":"AH Harrath","year":"2026","unstructured":"Harrath AH, Jalouli M, Al-Zharani M, Rahman MA (2026) Recent Update Targeting Autophagy-Apoptosis Crosstalk Using Bioactive Natural Products for Ovarian Cancer Treatment. Biomedicines 14:212. https:\/\/doi.org\/10.3390\/biomedicines14010212","journal-title":"Biomedicines"},{"key":"4949_CR167","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3892\/ijmm.2019.4228","volume":"44","author":"J Zhang","year":"2019","unstructured":"Zhang J, Wang Y, Bao C et al (2019) Curcumin\u2013loaded PEG\u2013PDLLA nanoparticles for attenuating palmitate\u2013induced oxidative stress and cardiomyocyte apoptosis through AMPK pathway. Int J Mol Med 44:672\u2013682. https:\/\/doi.org\/10.3892\/ijmm.2019.4228","journal-title":"Int J Mol Med"},{"key":"4949_CR168","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/JHC.S399855","volume":"10","author":"T Duan","year":"2023","unstructured":"Duan T, Yang X, Kuang J et al (2023) ULK1 Depletion Protects Mice from Diethylnitrosamine-Induced Hepatocarcinogenesis by Promoting Apoptosis and Inhibiting Autophagy. JHC 10:315\u2013325. https:\/\/doi.org\/10.2147\/JHC.S399855","journal-title":"JHC"},{"key":"4949_CR169","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41419-019-1492-6","volume":"10","author":"G Zhang","year":"2019","unstructured":"Zhang G, He J, Ye X et al (2019) \u03b2-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38\/ERK MAPK signalling in human hepatocellular carcinoma. Cell Death Dis 10:255. https:\/\/doi.org\/10.1038\/s41419-019-1492-6","journal-title":"Cell Death Dis"},{"key":"4949_CR170","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13020-025-01061-w","volume":"20","author":"D Yin","year":"2025","unstructured":"Yin D, Li X, Yang X et al (2025) Huqi formula suppresses hepatocellular carcinoma growth by modulating the PI3K\/AKT\/mTOR pathway and promoting T cell infiltration. Chin Med 20:25. https:\/\/doi.org\/10.1186\/s13020-025-01061-w","journal-title":"Chin Med"},{"key":"4949_CR171","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4161\/cc.27355","volume":"13","author":"A Alayev","year":"2014","unstructured":"Alayev A, Sun Y, Snyder RB, Berger SM, Yu JJ, Holz MK (2014) Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells. Cell Cycle 13:371\u2013382. https:\/\/doi.org\/10.4161\/cc.27355","journal-title":"Cell Cycle"},{"key":"4949_CR172","doi-asserted-by":"publisher","first-page":"1700610","DOI":"10.1002\/mnfr.201700610","volume":"62","author":"S Tomas-Hern\u00e1ndez","year":"2018","unstructured":"Tomas-Hern\u00e1ndez S, Blanco J, Rojas C et al (2018) Resveratrol Potently Counteracts Quercetin Starvation\u2010Induced Autophagy and Sensitizes HepG2 Cancer Cells to Apoptosis. Mol Nutr Food Res 62:1700610. https:\/\/doi.org\/10.1002\/mnfr.201700610","journal-title":"Mol Nutr Food Res"},{"key":"4949_CR173","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.2967\/jnumed.123.265712","volume":"64","author":"M Wu","year":"2023","unstructured":"Wu M, Wang Y, Yang Q et al (2023) Comparison of Baseline 68Ga-FAPI and 18F-FDG PET\/CT for Prediction of Response and Clinical Outcome in Patients with Unresectable Hepatocellular Carcinoma Treated with PD-1 Inhibitor and Lenvatinib. J Nucl Med 64:1532\u20131539. https:\/\/doi.org\/10.2967\/jnumed.123.265712","journal-title":"J Nucl Med"},{"key":"4949_CR174","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-019-1075-2","volume":"18","author":"L Cao","year":"2019","unstructured":"Cao L, Yang X, Chen Y, Zhang D, Jiang X-F, Xue P (2019) Exosomal miR-21 regulates the TETs\/PTENp1\/PTEN pathway to promote hepatocellular carcinoma growth. Mol Cancer 18:148. https:\/\/doi.org\/10.1186\/s12943-019-1075-2","journal-title":"Mol Cancer"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04949-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00280-026-04949-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-026-04949-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:02:07Z","timestamp":1789675327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00280-026-04949-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":174,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4949"],"URL":"https:\/\/doi.org\/10.1007\/s00280-026-04949-y","relation":{},"ISSN":["1432-0843"],"issn-type":[{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"4 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"101"}}